摘要
目的探讨经皮内镜治疗L5/S1腰椎椎间盘突出症的入路选择。方法 2011年8月~2012年8月符合入选条件的68例L5/S1腰椎椎间盘突出患者按入院奇偶顺序分成2组,椎板间入路组34例,椎间孔入路组34例。对2种手术入路的手术时间、透视次数、术中患者耐受情况、患者疗效满意度、术后残余症状、并发症及术前术后疼痛视觉模拟量表(visual analogue scale,VAS)评分进行比较。结果椎板间入路组有4例术中改为椎间孔入路,椎间孔入路组有7例改为椎板间入路,经椎板间入路和椎间孔入路手术时间分别是(50.2±7.0)min、(61.9±9.6)min(P<0.05),术中透视次数分别为5.4±2.3次、10.3±2.5次(P<0.05),2种入路治疗后腿痛术后即刻及术后3个月VAS评分与术前相比差异均有统计学意义(P<0.05)。改良MacNab标准评定2组间差异无统计学意义(P>0.05)。结论经皮内镜下治疗L5/S1腰椎椎间盘突出症经椎板间或经椎间孔入路治疗各有特点,且均能取得优良的临床疗效,但需针对患者的解剖情况、影像定位及临床表型选择适宜的个体化手术入路。
Objective To discuss approach selection of L5/S1 lumbar disc herniation treated by percutaneous endoscopy. Methods From August 2011 to August 2012, 68 patients with L5/S1 disc herniation admitted were divided into 2 groups by admission parity order, 34 patients in interlaminar approach group, 34 cases in transforaminal approach group, compared operation time, fluoroscopy times, patients’ tolerance , therapy efficacy, postoperative residual symptoms, complications and preoperative and postoperative visual analogue scale (VAS) scores. Results Four cases changed to transforaminal approach in interlaminar group, 7 cases changed to interlaminar approach in transforaminal group, interlaminar group and transforaminal group operation time was (50.2±7.0)min,(61.9±9.6)min(P〈0.05); perspective times were 5.4±2.3, 10.3±2.5(P〈0.05), compared leg pain VAS score postoperative and after surgery 3 months to preoperative, there were statistically significant (P〈0.05). The improved MacNab was no statistically significant between 2 groups (P〉0.05). Conclusion L5/S1 lumbar disc herniation treated by percutaneous endoscopic via interlaminar and transforaminal approach have achieved excellent clinical efficacy. But the patient’s anatomy, image positioning and clinical symptom should be combined to develop appropriate individualized surgical approach.
出处
《脊柱外科杂志》
2013年第2期97-100,共4页
Journal of Spinal Surgery
关键词
腰椎
椎间盘移位
内窥镜检查
临床方案
Lumbar vertebrae
Intervertebral disk displacement
Endoscopy
Clinical protocols